Compare GeneDx Holdings Corp (WGS) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Zillow Group Inc Class C — how do they compare? GeneDx Holdings Corp trades at $82.71 (market cap $2.44B), while Zillow Group Inc Class C trades at $33.24 (market cap $7.68B). The key difference: Zillow Group Inc Class C is far larger — about 3.1× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| WGS | Z | |
|---|---|---|
Market Cap | $2.44B | $7.68B |
Sector | Technology | Media |
52-Week High | $167.51 | $90.35 |
52-Week Low | $34.51 | $29.41 |
Enterprise Value | $2.48B | $7.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Zillow Group (Z) trades at $33.26, down 1.45% on the day, amid a bearish technical signal and mixed sentiment. The stock shows strong revenue growth, with Q2 2026 results beating expectations, but faces near-term pressure from a securities class action lawsuit. Valuation metrics like a P/E of 148.41 reflect high growth expectations, while profitability remains modest with a net income margin of 1.96%.
The outlook is cautious; analyst consensus targets $52.00, implying upside, but legal risks and a challenging real estate market pose headwinds. Investors should weigh the company's monetization progress against litigation overhangs and macroeconomic sensitivity for balanced risk-reward assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
